Evidence map›Paper›PMID 35784644›Full record

ArticleCell reports methods2022

Rapid detection of an Ebola biomarker with optical microring resonators.

Abraham J Qavi, Krista Meserve, M Javad Aman, Hong Vu, Larry Zeitlin, John M Dye, Jeffrey W Froude, Daisy W Leung, Lan Yang, Frederick W Holtsberg and 2 more

Abstract read
In one paragraph

Article in Cell reports methods, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Abraham J QaviDepartment of Pathology & Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA.
Krista MeserveDepartment of Chemistry, University of Michigan, Ann Arbor, MI 48109, USA.
M Javad AmanIntegrated Biotherapeutics, Rockville, MD 20850, USA.
Hong VuIntegrated Biotherapeutics, Rockville, MD 20850, USA.
Larry ZeitlinMapp Biopharmaceutical, Inc., San Diego, CA 92121, USA.
John M DyeUnited States Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD 21702, USA.
Jeffrey W FroudeUnited States Army Nuclear and Countering Weapons of Mass Destruction Agency, Fort Belvoir, VA 22060, USA.
Daisy W LeungDepartment of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA.
Lan YangDepartment of Electrical & Systems Engineering, Washington University in St. Louis, St. Louis, MO 63130, USA.
Frederick W HoltsbergIntegrated Biotherapeutics, Rockville, MD 20850, USA.
Ryan C BaileyDepartment of Chemistry, University of Michigan, Ann Arbor, MI 48109, USA.
Gaya K AmarasingheDepartment of Pathology & Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA.

Funding

Virology BSL4 CoreP01AI120943 · NIAID · WASHINGTON UNIVERSITY · PI ROBERT A DAVEY · 2016 to 2026
$30.2M
TRAINING IN THE IMMUNOBIOLOGY AND MOLECULAR CELL BIOLOGY OF CANCERT32CA009547 · NCI · WASHINGTON UNIVERSITY · PI ROBERT DAVID SCHREIBER · 1986 to 2026
$12.1M
Precision immunoprofiling to reveal diagnostic biomarkers of latent TB infectionR01AI141591 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI BAILEY, RYAN C, ESCALANTE, PATRICIO · 2019 to 2022
$2.9M
Multi-platform High Throughput Screens for Filoviral Replication InhibitorsR01AI123926 · NIAID · WASHINGTON UNIVERSITY · PI AMARASINGHE, GAYA K. · 2016 to 2018
$2.1M
STRUCTURAL BASIS FOR IMMUNE EVASION BY RSV NON-STRUCTURAL PROTEINSR01AI107056 · NIAID · WASHINGTON UNIVERSITY · PI LEUNG, DAISY W · 2013 to 2017
$1.9M
Development of Optofluidic Resonators for Filoviral DetectionK08EB033409 · NIBIB · WASHINGTON UNIVERSITY · PI QAVI, ABRAHAM JALEEL · 2022 to 2025
$759k
Whispering Gallery Mode Devices for the Rapid Detection of Pan-FilovirusesR41AI152745 · NIAID · INTEGRATED BIOTHERAPEUTICS, INC. · PI AMARASINGHE, GAYA K., HOLTSBERG, FREDERICK WAYNE · 2020 to 2021
$592k
NCI NIH HHS T32 CA009547NIAID NIH HHS P01 AI120943NIAID NIH HHS R01 AI107056NIAID NIH HHS R01 AI123926NIAID NIH HHS R01 AI141591NIAID NIH HHS R41 AI152745NIBIB NIH HHS K08 EB033409
6 · The paper itself

Abstract

Ebola virus (EBOV) is a highly infectious pathogen, with a case mortality rate as high as 89%. Rapid therapeutic treatments and supportive measures can drastically improve patient outcome; however, the symptoms of EBOV disease (EVD) lack specificity from other endemic diseases. Given the high mortality and significant symptom overlap, there is a critical need for sensitive, rapid diagnostics for EVD. Facile diagnosis of EVD remains a challenge. Here, we describe a rapid and sensitive diagnostic for EVD through microring resonator sensors in conjunction with a unique biomarker of EBOV infection, soluble glycoprotein (sGP). Microring resonator sensors detected sGP in under 40 min with a limit of detection (LOD) as low as 1.00 ng/mL in serum. Furthermore, we validated our assay with the detection of sGP in serum from EBOV-infected non-human primates. Our results demonstrate the utility of a high-sensitivity diagnostic platform for detection of sGP for diagnosis of EVD.

Indexed as

EbolavirusHemorrhagic Fever, EbolaAnimalsHumansLimit of DetectionRapid Diagnostic TestsbiosensorsdiagnosticsEbola virusfilovirusesimmunoassayphotonics

Identifiers

PMID35784644
PMCPMC9243524

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.